164 related articles for article (PubMed ID: 31348233)
1. Evaluation of PTEN and CD4+FOXP3+ T cell expressions as diagnostic and predictive factors in endometrial cancer: A case control study.
Xi Z; Jing L; Le-Ni K; Zhu L; Ze-Wen D; Hui Y; Ming-Rong X; Guang-Dong L
Medicine (Baltimore); 2019 Jul; 98(30):e16345. PubMed ID: 31348233
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer.
Yamagami W; Susumu N; Tanaka H; Hirasawa A; Banno K; Suzuki N; Tsuda H; Tsukazaki K; Aoki D
Int J Gynecol Cancer; 2011 Dec; 21(9):1628-34. PubMed ID: 21897268
[TBL] [Abstract][Full Text] [Related]
3. Potential clinical value of interleukin-31 and interleukin-33 with their receptors expression as diagnostic and predictive factors in endometrial cancer: a case-control study.
Zeng X; Li J; Kang LN; Xi MR; Liao GD
Int J Clin Exp Pathol; 2020; 13(6):1324-1332. PubMed ID: 32661468
[No Abstract] [Full Text] [Related]
4. PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
Tao Y; Liang B
Pathol Res Pract; 2020 Jun; 216(6):152943. PubMed ID: 32279917
[TBL] [Abstract][Full Text] [Related]
5. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
6. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
7. Expressions and significances of TTF-1 and PTEN in early endometrial cancer.
Zhang HM; Fan TT; Li W; Li XX
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):20-26. PubMed ID: 28745797
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.
Li W; Wang Y; Fang X; Zhou M; Li Y; Dong Y; Wang R
Med Sci Monit; 2017 Feb; 23():938-947. PubMed ID: 28220037
[TBL] [Abstract][Full Text] [Related]
9. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of expression of the PTEN gene, oestrogen and progesterone receptors as diagnostic and predictive factors in endometrial cancer.
Samulak D; Grosman-Dziewiszek P; Michalska MM; Mojs E; Samulak K; Romanowicz H; Smolarz B
Pathol Oncol Res; 2014 Jan; 20(1):191-6. PubMed ID: 24030769
[TBL] [Abstract][Full Text] [Related]
11. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.
Monte NM; Webster KA; Neuberg D; Dressler GR; Mutter GL
Cancer Res; 2010 Aug; 70(15):6225-32. PubMed ID: 20631067
[TBL] [Abstract][Full Text] [Related]
12. Expression of PTEN in endometrial liquid-based cytology.
Di Lorito A; Zappacosta R; Capanna S; Gatta DM; Rosini S; Schmitt FC
Acta Cytol; 2014; 58(5):495-500. PubMed ID: 25358681
[TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of the PTEN protein and matrix metalloproteinase-2 in endometrial cysts, endometrioid and clear cell ovarian cancer.
Brucka A; Szyłło K
Ginekol Pol; 2013 May; 84(5):344-51. PubMed ID: 23819399
[TBL] [Abstract][Full Text] [Related]
14. PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors.
Yang HP; Meeker A; Guido R; Gunter MJ; Huang GS; Luhn P; d'Ambrosio L; Wentzensen N; Sherman ME
Cancer Causes Control; 2015 Dec; 26(12):1729-36. PubMed ID: 26376893
[TBL] [Abstract][Full Text] [Related]
15. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
[TBL] [Abstract][Full Text] [Related]
16. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients.
Geletina NS; Kobelev VS; Babayants EV; Feng L; Pustylnyak VO; Gulyaeva LF
Gene; 2018 May; 655():20-24. PubMed ID: 29477866
[TBL] [Abstract][Full Text] [Related]
17. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
[TBL] [Abstract][Full Text] [Related]
20. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression.
Baak JP; Van Diermen B; Steinbakk A; Janssen E; Skaland I; Mutter GL; Fiane B; Løvslett K
Hum Pathol; 2005 May; 36(5):555-61. PubMed ID: 15948123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
